NFκB modulators in a model of glucocorticoid resistant, childhood acute lymphoblastic leukemia

Leukemia Research

Volumn 34, Issue 10, 2010, Pages 1366-1373

  Nicholson, Lindsay ^a   Hall, Andrew G ^a   Redfern, Christopher P ^a   Irving, Julie ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

Childhood acute lymphoblastic leukaemia; Glucocorticoid resistance; NF B

Indexed keywords

DEXAMETHASONE; GLUCOCORTICOID INDUCED LEUCINE ZIPPER PROTEIN; GLUCOCORTICOID RECEPTOR; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE KINASE; RAF PROTEIN; RAS PROTEIN; REGULATOR PROTEIN; TRANSCRIPTION FACTOR REL; TRANSCRIPTION FACTOR RELA; UNCLASSIFIED DRUG; GLUCOCORTICOID; I KAPPA B; NF KAPPAB INHIBITOR ALPHA; NF-KAPPAB INHIBITOR ALPHA; TRANSCRIPTION FACTOR; TSC22D3 PROTEIN, HUMAN;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; APOPTOSIS; ARTICLE; CANCER RESISTANCE; CELL SURVIVAL; CHILD; CHILDHOOD LEUKEMIA; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG SENSITIVITY; FEMALE; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN TRANSPORT; SCHOOL CHILD; SIGNAL TRANSDUCTION; UPREGULATION; DRUG RESISTANCE; INFANT; PHYSIOLOGY; TUMOR CELL LINE;

ADOLESCENT; CELL LINE, TUMOR; CHILD; CHILD, PRESCHOOL; DRUG RESISTANCE, NEOPLASM; FEMALE; GLUCOCORTICOIDS; HUMANS; I-KAPPA B PROTEINS; INFANT; MALE; NF-KAPPA B; PRECURSOR B-CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; RECEPTORS, GLUCOCORTICOID; TRANSCRIPTION FACTORS;

EID: 77955981207     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.leukres.2009.12.014     Document Type: Article

References (41)

1. Wang J.C., Derynck M.K., Nonaka D.F., Khodabakhsh D.B., Haqq C., Yamamoto K.R. Chromatin immunoprecipitation (ChIP) scanning identifies primary glucocorticoid receptor target genes. Proc Natl Acad Sci USA 2004, 101:15603-15608.
2. Ray A., Prefontaine K.E. Physical association and functional antagonism between the p65 subunit of transcription factor NF-kappa B and the glucocorticoid receptor. Proc Natl Acad Sci USA 1994, 91:752-756.
3. Herr I., Gassler N., Friess H., Buchler M.W. Regulation of differential pro- and anti-apoptotic signaling by glucocorticoids. Apoptosis 2007, 12:271-291.
4. Riehm H., Reiter A., Schrappe M., Berthold F., Dopfer R., Gerein V., et al. Corticosteroid-dependent reduction of leukocyte count in blood as a prognostic factor in acute lymphoblastic leukemia in childhood (therapy study ALL-BFM 83). Klin Padiatr 1987, 199:151-160.
5. Reiter A., Schrappe M., Ludwig W.D., Hiddemann W., Sauter S., Henze G., et al. Chemotherapy in 998 unselected childhood acute lymphoblastic leukemia patients. Results and conclusions of the multicenter trial ALL-BFM 86. Blood 1994, 84:3122-3133.
6. Schrappe M., Reiter A., Zimmermann M., Harbott J., Ludwig W.D., Henze G., et al. Long-term results of four consecutive trials in childhood ALL performed by the ALL-BFM study group from 1981 to 1995. Berlin-Frankfurt-Munster. Leukemia 2000, 14:2205-2222.
7. Klumper E., Pieters R., Veerman A., Huismans D., Loonen A., Hahlen K., et al. In vitro cellular drug resistance in children with relapsed/refractory acute lymphoblastic leukemia. Blood 1995, 86:3861-3868.
8. Kaspers G.J., Wijnands J.J., Hartmann R., Huismans L., Loonen A.H., Stackelberg A., et al. Immunophenotypic cell lineage and in vitro cellular drug resistance in childhood relapsed acute lymphoblastic leukaemia. Eur J Cancer 2005, 41:1300-1303.
9. Kofler R., Schmidt S., Kofler A., Ausserlechner M.J. Resistance to glucocorticoid-induced apoptosis in lymphoblastic leukemia. J Endocrinol 2003, 178:19-27.
10. Haarman E.G., Kaspers G.J., Veerman A.J. Glucocorticoid resistance in childhood leukaemia: mechanisms and modulation. Br J Haematol 2003, 120:919-929.
11. Irving J.A., Minto L., Bailey S., Hall A.G. Loss of heterozygosity and somatic mutations of the glucocorticoid receptor gene are rarely found at relapse in pediatric acute lymphoblastic leukemia but may occur in a subpopulation early in the disease course. Cancer Res 2005, 65:9712-9718.
12. Tissing W.J., Meijerink J.P., den Boer M.L., Brinkhof B., van Rossum E.F., van Wering E.R., et al. Genetic variations in the glucocorticoid receptor gene are not related to glucocorticoid resistance in childhood acute lymphoblastic leukemia. Clin Cancer Res 2005, 11:6050-6056.
13. Schmidt S., Irving J.A., Minto L., Matheson E., Nicholson L., Ploner A., et al. Glucocorticoid resistance in two key models of acute lymphoblastic leukemia occurs at the level of the glucocorticoid receptor. FASEB J 2006, 20:2600-2602.
14. Matheson E.C., Hall A.G. Assessment of mismatch repair function in leukaemic cell lines and blasts from children with acute lymphoblastic leukaemia. Carcinogenesis 2003, 24:31-38.
15. Chauhan D., Auclair D., Robinson E.K., Hideshima T., Li G., Podar K., et al. Identification of genes regulated by dexamethasone in multiple myeloma cells using oligonucleotide arrays. Oncogene 2002, 21:1346-1358.
16. Miller A.L., Komak S., Webb M.S., Leiter E.H., Thompson E.B. Gene expression profiling of leukemic cells and primary thymocytes predicts a signature for apoptotic sensitivity to glucocorticoids. Cancer Cell Int 2007, 7:18.
17. Schmidt S., Rainer J., Riml S., Ploner C., Jesacher S., Achmuller C., et al. Identification of glucocorticoid-response genes in children with acute lymphoblastic leukemia. Blood 2006, 107:2061-2069.
18. Caldenhoven E., Liden J., Wissink S., Van de Stolpe A., Raaijmakers J., Koenderman L., et al. Negative cross-talk between RelA and the glucocorticoid receptor: a possible mechanism for the antiinflammatory action of glucocorticoids. Mol Endocrinol 1995, 9:401-412.
19. Ayroldi E., Migliorati G., Bruscoli S., Marchetti C., Zollo O., Cannarile L., et al. Modulation of T-cell activation by the glucocorticoid-induced leucine zipper factor via inhibition of nuclear factor kappaB. Blood 2001, 98:743-753.
20. Perkins N.D. Integrating cell-signalling pathways with NF-kappaB and IKK function. Nat Rev Mol Cell Biol 2007, 8:49-62.
21. Novac N., Baus D., Dostert A., Heinzel T. Competition between glucocorticoid receptor and NFkappaB for control of the human FasL promoter. FASEB J 2006, 20:1074-1081.
22. Sheppard K.A., Phelps K.M., Williams A.J., Thanos D., Glass C.K., Rosenfeld M.G., et al. Nuclear integration of glucocorticoid receptor and nuclear factor-kappaB signaling by CREB-binding protein and steroid receptor coactivator-1. J Biol Chem 1998, 273:29291-29294.
23. Auphan N., DiDonato J.A., Rosette C., Helmberg A., Karin M. Immunosuppression by glucocorticoids: inhibition of NF-kappa B activity through induction of I kappa B synthesis. Science 1995, 270:286-290.
24. Scheinman R.I., Cogswell P.C., Lofquist A.K., Baldwin A.S. Role of transcriptional activation of I kappa B alpha in mediation of immunosuppression by glucocorticoids. Science 1995, 270:283-286.
25. Petro J.B., Rahman S.M., Ballard D.W., Khan W.N. Bruton's tyrosine kinase is required for activation of IkappaB kinase and nuclear factor kappaB in response to B cell receptor engagement. J Exp Med 2000, 191:1745-1754.
26. Parcellier A., Schmitt E., Gurbuxani S., Seigneurin-Berny D., Pance A., Chantome A., et al. HSP27 is a ubiquitin-binding protein involved in I-kappaBalpha proteasomal degradation. Mol Cell Biol 2003, 23:5790-5802.
27. Kordes U., Krappmann D., Heissmeyer V., Ludwig W.D., Scheidereit C. Transcription factor NF-kappaB is constitutively activated in acute lymphoblastic leukemia cells. Leukemia 2000, 14:399-402.
28. Zhou M., Gu L., Li F., Zhu Y., Woods W.G., Findley H.W. DNA damage induces a novel p53-survivin signaling pathway regulating cell cycle and apoptosis in acute lymphoblastic leukemia cells. J Pharmacol Exp Ther 2002, 303:124-131.
29. Olnes M.I., Kurl R.N. Isolation of nuclear extracts from fragile cells: a simplified procedure applied to thymocytes. Biotechniques 1994, 17:828-829.
30. Ritz C., Streibig J. Bioassay analysis using R. J Stat Softw 2005, 12.
31. Team R.D.C. R: A language and environment for statistical computing 2008, R Foundation for Statistical Computing, Vienna, Austria.
32. Feldhahn N., Rio P., Soh B.N., Liedtke S., Sprangers M., Klein F., et al. Deficiency of Bruton's tyrosine kinase in B cell precursor leukemia cells. Proc Natl Acad Sci USA 2005, 102:13266-13271.
33. Bachmann P.S., Gorman R., Papa R.A., Bardell J.E., Ford J., Kees U.R., et al. Divergent mechanisms of glucocorticoid resistance in experimental models of pediatric acute lymphoblastic leukemia. Cancer Res 2007, 67:4482-4490.
34. Ayroldi E., Zollo O., Macchiarulo A., Di Marco B., Marchetti C., Riccardi C. Glucocorticoid-induced leucine zipper inhibits the Raf-extracellular signal-regulated kinase pathway by binding to Raf-1. Mol Cell Biol 2002, 22:7929-7941.
35. Tanaka T., Okabe T., Gondo S., Fukuda M., Yamamoto M., Umemura T., et al. Modification of glucocorticoid sensitivity by MAP kinase signaling pathways in glucocorticoid-induced T-cell apoptosis. Exp Hematol 2006, 34:1542-1552.
36. Aguilera C., Hoya-Arias R., Haegeman G., Espinosa L., Bigas A. Recruitment of IkappaBalpha to the hes1 promoter is associated with transcriptional repression. Proc Natl Acad Sci USA 2004, 101:16537-16542.
37. Gruber G., Carlet M., Turtscher E., Meister B., Irving J.A., Ploner C., et al. Levels of glucocorticoid receptor and its ligand determine sensitivity and kinetics of glucocorticoid-induced leukemia apoptosis. Leukemia 2009, 23:820-823.
38. Meyers J.A., Taverna J., Chaves J., Makkinje A., Lerner A. Phosphodiesterase 4 inhibitors augment levels of glucocorticoid receptor in B cell chronic lymphocytic leukemia but not in normal circulating hematopoietic cells. Clin Cancer Res 2007, 13:4920-4927.
39. Le Drean Y., Mincheneau N., Le Goff P., Michel D. Potentiation of glucocorticoid receptor transcriptional activity by sumoylation. Endocrinology 2002, 143:3482-3489.
40. Bodwell J.E., Webster J.C., Jewell C.M., Cidlowski J.A., Hu J.M., Munck A. Glucocorticoid receptor phosphorylation: overview, function and cell cycle-dependence. J Steroid Biochem Mol Biol 1998, 65:91-99.
41. Pottier N., Yang W., Assem M., Panetta J.C., Pei D., Paugh S.W., et al. The SWI/SNF chromatin-remodeling complex and glucocorticoid resistance in acute lymphoblastic leukemia. J Natl Cancer Inst 2008, 100:1792-1803.